BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 34570453)

  • 1. Clinical Targeting of Altered Metabolism in High-Grade Glioma.
    Scott AJ; Lyssiotis CA; Wahl DR
    Cancer J; 2021 Sep-Oct 01; 27(5):386-394. PubMed ID: 34570453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytotoxic and molecular chemotherapy for high-grade glioma: an emerging strategy for the future.
    Cavaliere R; Newton H
    Expert Opin Pharmacother; 2006 Apr; 7(6):749-65. PubMed ID: 16556090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted Therapeutics in Patients With High-Grade Gliomas: Past, Present, and Future.
    Chen R; Cohen AL; Colman H
    Curr Treat Options Oncol; 2016 Aug; 17(8):42. PubMed ID: 27334978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotherapy in glioma.
    Taal W; Bromberg JE; van den Bent MJ
    CNS Oncol; 2015; 4(3):179-92. PubMed ID: 25906059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel approaches to glioma drug design and drug screening.
    Patil SA; Hosni-Ahmed A; Jones TS; Patil R; Pfeffer LM; Miller DD
    Expert Opin Drug Discov; 2013 Sep; 8(9):1135-51. PubMed ID: 23738794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current state and future perspective of drug repurposing in malignant glioma.
    Siegelin MD; Schneider E; Westhoff MA; Wirtz CR; Karpel-Massler G
    Semin Cancer Biol; 2021 Jan; 68():92-104. PubMed ID: 31734137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigational new drugs for brain cancer.
    Staedtke V; Bai RY; Laterra J
    Expert Opin Investig Drugs; 2016 Aug; 25(8):937-56. PubMed ID: 27170161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiogenesis in malignant glioma--a target for antitumor therapy?
    Tuettenberg J; Friedel C; Vajkoczy P
    Crit Rev Oncol Hematol; 2006 Sep; 59(3):181-93. PubMed ID: 16860996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Promising new therapies for malignant gliomas.
    Fine HA
    Cancer J; 2007; 13(6):349-54. PubMed ID: 18032970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting core (mutated) pathways of high-grade gliomas: challenges of intrinsic resistance and drug efflux.
    Lin F; de Gooijer MC; Hanekamp D; Brandsma D; Beijnen JH; van Tellingen O
    CNS Oncol; 2013 May; 2(3):271-88. PubMed ID: 25054467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel chemotherapeutic approaches to brain tumors.
    Dropcho EJ
    Hematol Oncol Clin North Am; 2001 Dec; 15(6):1027-52. PubMed ID: 11770297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current and future directions for Phase II trials in high-grade glioma.
    Alexander BM; Lee EQ; Reardon DA; Wen PY
    Expert Rev Neurother; 2013 Apr; 13(4):369-87. PubMed ID: 23545053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The challenges and the promise of molecular targeted therapy in malignant gliomas.
    Wang H; Xu T; Jiang Y; Xu H; Yan Y; Fu D; Chen J
    Neoplasia; 2015 Mar; 17(3):239-55. PubMed ID: 25810009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting Ras-RAF-ERK and its interactive pathways as a novel therapy for malignant gliomas.
    Lo HW
    Curr Cancer Drug Targets; 2010 Dec; 10(8):840-8. PubMed ID: 20718706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Designing new drugs for high grade gliomas.
    Frosina G
    Curr Pharm Des; 2011; 17(23):2368-9. PubMed ID: 21827412
    [No Abstract]   [Full Text] [Related]  

  • 16. Role of tyrosine kinase inhibitors in the management of high-grade gliomas.
    Ahluwalia MS; Patel M; Peereboom DM
    Expert Rev Anticancer Ther; 2011 Nov; 11(11):1739-48. PubMed ID: 22050023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell surface receptors in malignant glioma.
    Li YM; Hall WA
    Neurosurgery; 2011 Oct; 69(4):980-94; discussion 994. PubMed ID: 21522029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapy for gliomas.
    Chang SM; Prados MD
    Curr Opin Oncol; 1995 May; 7(3):207-13. PubMed ID: 7654821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New treatment strategies for malignant gliomas.
    Sathornsumetee S; Rich JN
    Expert Rev Anticancer Ther; 2006 Jul; 6(7):1087-104. PubMed ID: 16831080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NOS Expression and NO Function in Glioma and Implications for Patient Therapies.
    Tran AN; Boyd NH; Walker K; Hjelmeland AB
    Antioxid Redox Signal; 2017 Jun; 26(17):986-999. PubMed ID: 27411305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.